National Biotechnology Conference

April 23-26

10:00 a.m - 6:00 p.m PT

Marriott Downtown, Philadelphia, PA 19107

booth #916

Booth #8

We look forward to meeting with you at NBC.

Request a meeting with our scientific experts in Philadelphia, booth #916, to learn how we help our clients advance their drug modality.

Schedule a Meeting

BioAgilytix Presentations at NBC

Hot Topic Panel Presentations:

Intro to Biomarkers: An Expert Panel Discussion

Panelist: Amanda Hays, PhD

Tuesday, April 25th

3:00 p.m – 4:00 p.m

Rapid Fire Presentations:

Rapid Fire: Predictive Biomarker Strategies to De-Risk Drug Developments 2

Strategy for Assessing Stability in Multiplexed Cytokine Panels

Presenter: Christian Braithwaite, M.S. - Associate Director

Monday, October 23, 2023

3:45 – 4:00 p.m.

Location: 311 CD West

Rapid Fire: Setting up for Success -- Considerations for Study Design in the Context of Bioanalysis 2

Platform Methods: Universal Immunoaffinity-LCMS Bioanalytical Methods for Drug Development Platforms

Presenter: Ben Nie, PhD - Scientist III

Monday, October 23, 2023

3:45 – 4:00 p.m.

Location: 311 GH West

Rapid Fire Presentations:

Considerations for Developing and Validating an Anti-AAV9 ADA Assay

Presenter: Sara Alhakeem, PhD

Monday, April 24th.

2:45 p.m. – 3:00 p.m.

qPCR Biodistribution and Shedding Assessment Strategy in Gene Therapy Studies

Presenter: Amanda Hays, PhD

Monday, April 24th

3:15 p.m – 3:30 p.m

Challenges in Developing Robust Hybridization Immunoassays

Presenter: Liz Nolff, MS

Wednesday, April 26th

2:45 p.m – 3:00 p.m

Poster Presentations:

Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR

Presenter: Brian D. Bower, PhD

Submission ID# 1452441

Accurately measure the immunogenicity and pharmacokinetics (PK) of your biotherapeutics and advanced modalities

We provide the global, best-in-class bioanalytical capabilities needed to address even the most challenging biomarker, immunogenicity, PK, and cell-based assay requirements.

Detect your drug product or it’s downstream effects with an experienced molecular assay partner

We have a proven track record working with biotherapeutics and advanced modalities. We have been successfully supporting these programs across a variety of delivery mechanisms and matrices for over 10 years.

Rely on services backed by global good manufacturing practices (GMP)

We offer a full suite of bioanalytical lifecycle services supporting the release, production, and manufacturing of therapeutic drugs. Our GMP-driven service offerings include immunoassays, cell-based assays, and molecular assays for potency assessments.

Access our vast biomarker experience to better understand the PD of your therapeutic

We offer a wide variety of off-the-shelf biomarker assays, including 120+ validated biomarker assays for a range of disease states..

Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form, and an expert will reach out to schedule a meeting with you onsite.

About the event

PharmSci 360 is an annual event organized by the American Association of Pharmaceutical Scientists (AAPS). It offers a platform for scientists, researchers, and industry professionals to share knowledge and advancements in the field of pharmaceutical science and technology. The event features educational sessions, networking opportunities, and exhibits showcasing the latest innovations in pharmaceuticals.

Schedule a meeting with our experts onsite

Schedule a meeting

Speak with our scientific experts onsite to discuss your project.

Cookie Preferences

Site Map